Glyconutrient Research-NDA Unpublished Reports

Experiments and investigations required by the FDA for a new drug application (NDA) conducted under the detailed monitoring and documentation with audit standards of this federal agency.  These reports were held as confidential until their recent release and have not been available to any party outside the FDA. 

NOTE:  Some listings of titles in this bibliography are only the abstract or executive summary of the complete manuscript of the full presentation available with slides, graphs, and photos or as a recording. 

Bibliography Listings for Acemannan
1987 to 1993


Entry Prime Author Title Type Journal/Conf JAMA Citing Year







1 McDaniel, HR Evaluation of Polymannoacete (Carrisyn) in the Treatment of AIDS ABS PUB American Federal for Clinical Research San Diego, CA 1987







2 McDaniel, HR A Clinical Pilot Study Using Carrisyn in the Treatment of Acquired Immunodeficiency Syndrome (AIDS) ABS PUB American Society of Clinical Pathologists Scientific Assembly New Orleans, LA 1987







3 McDaniel, HR In Vitro Studies on Polymannocetate (Carrisyn) for Antiviral Effect ABS American Society of Clinical Pathologists Scientific Assembly New Orleans, LA 1987







4 McDaniel, HR Identification of a Gigantic Circulating Monocytic Cell in Warm Blood Animals ABS American Society of Clinical Pathologists Scientific Assembly New Orleans, LA 1987







5 Carpenter, RH The Antiviral Effect of Polymannoacetate (Carrisyn) on Feline Rhinotracheitis ABS American Society of Clinical Pathologists Scientific Assembly New Orleans, LA 1987







6 McDaniel, HR An Extended Clinical Pilot Study Utilizing Acemannan (ACE-M) in HIV Patients ABS First International Conference on the Global Impact of AIDS London, England 1987







7 Eberendu, AR Isolation and Characterization of a New Antiviral Polysaccharide Extracted From Aloe Barbadensis Miller ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







8 McDaniel, HR In Vitro Studies on Acemannan (ACE-M) for Antiviral Effect ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







9 McDaniel, HR In Vitro Antiviral Effect of Acemannan (ACE-M) on Feline Rhinotracheitis (FRT) ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







10 Carpenter, RH In Vivo Antiviral Effect of Acemannan (ACE-M) on Feline Rhinotracheitis ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







11 Carpenter, RH Acemannan (ACE-M) Demonstrated as an Immune Adjuvant for Viral Vaccinations of Animals ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







12 White, A Antiviral Action of Acemannan (ACE-M) in a Measles Infected Cell Line ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







13 McDaniel, HR Identification of a Gigantic Circulating Monocytic Cell in Warm Blooded Animals Given Acemannan ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







14 McDaniel, HR The Significant of Identification of a Gigantic Circulating Monocytic Cell in Warm Blooded Animals ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







15 McDaniel, HR Inhibition of Human T-Cell Lymphotrophic Virus (HIV) in Vitro by Acemannan (ACE-M) ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







16 McDaniel, HR Evaluation of Acemannan (Carrisyn) in the Treatment of Acquired Immunodeficiency Syndrome (AIDS) Patients ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







17 McDaniel, HR A Clinical Pilot Study Using Carrisyn (Acemannan), ACE-M) Treatment of 16 Acquired Immunodeficiency Syndrome (AIDS) Patients ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







18 McDaniel, HR Prediction and Results Obtained Using Oral Acemannan (ACE-M) in 41 Symptomatic HIV Patients ABS Texas Society of Pathologists Scientific Poster Presentation Galveston, TX 1988







19 Measel, J The Effect of Carrisyn on the Immune System ABS Federation of American Societies for Experimental Biology 72nd Annual Meeting Las Vegas, NV 1988







20 McDaniel, HR Prediction and Results Obtained Using Oral Acemannan (ACE-M) in 41 Symptomatic HIV Patients ABS IV International Conference on AIDS Stockholm, Sweden 1988







21 Helderman, JH Enhancement of Afferent and Efferent Responses to Alloantigen by Acemannan (Carrisyn) ABS IV International Conference on AIDS Stockholm, Sweden 1988







22 McAnalley, BH Demonstration of In Vitro Antiviral Action of Acemannan (ACE-M) Against Multiple Viruses Including the HIV Virus ABS Fourth International Conference on Aids Stockholm, Sweden 1988







23 McDaniel, HR Clinical and Objective Evidence of a Favorable Response to Acemannan (ACE-M) Treated HIV-1 Patients ABS International Symposium on Medical Virology San Francisco, CA 1988







24 Kemp, MC Modification of Viral Glycoprotein Synthesis by Acemannan (ACE-M) ABS POS Fifth International Symposium on the Immunobiology of Proteins and Peptides Lake Louise, Alberta 1988







25 Kemp, MC Evidence for Systemic Immunomodulation by Acemannan (ACE-M) ABS POS Fifth International Symposium on the Immunobiology of Proteins and Peptides Lake Louise, Alberta 1988







26 Carpenter, RH Acemannan (ACE-M): A General Antiviral Having Anti-HIV-1 Activity ABS POS 16th International Congress of Chemotherapy Jerusalem, Israel 1989







27 McDaniel, HR Objective Evidence of a Favorable Clinical Response to Acemannan (ACE-M), a Biologic, in HIV-1 Patients (PT) ABS POS 16th International Congress of Chemotherapy Jerusalem, Israel 1989







28 McAnalley, BH A Unique Agent of Cell Molecular Language Discrimination: Acemannan (ACE-M) Induced Dysynthesis of GP-120 HIV-1 Envelope Glycoprotein (GP) ABS POS 16th International Congress of Chemotherapy Jerusalem, Israel 1989







29 Kemp, MC Effect(s) of Acemannan (Carrisyn) on the Replication of Enveloped Viruses ABS 29th Interscience Conference on Antimicrobial Agents and Chemotherapy Houston, TX 1989







30 McDaniel, HR Prognostic Criteria for Evaluating the Clinical Efficacy of Acemannan (ACE-M) for the Treatment of Symptomatic HIV-1 Patients ABS 29th Interscience Conference on Antimicrobial Agents and Chemotherapy Houston, TX 1989







31 Kahlon, JB Dose Dependent Inhibition of HIV Replication in the Presence of ACE_M in Vitro ABS International Symposium on Antiviral Chemotherapy Porto Cervo, Sardinia, Italy 1989







32 Kahlon, JB Effect of Acemannan (ACE-M) on T-Cell Proliferation and HIV-1/LAV Replication in Vitro ABS 6th International Conference on Comparative and Applied Virology Alberta, Canada 1989







33 McDaniel, HR Extended Survival and Prognostic criteria for Acemannan (ACE-M) Treated HIV-1 Patients (PTS) ABS Third International Conference on Antiviral Research Brussells, Belgium 1990







34 Kemp, MC In Vitro Evaluation of the Antiviral Effects of Acemannan on the Replication and Pathogenesis of HIV-1 and Other Enveloped Viruses: Modification of the Processing of Glycoprotein Precursors ABS Third International Conference on Antiviral Research Brussells, Belgium 1990







35 McDaniel, HR Extended Treatment of HIV-1 Patients (PTS) with Oral Acemannan (ACE-M): An Immune Modulator ABS Sixth International Symposium on Infections in the Immunocomprised Host Peebles, Scotland 1990







36 Weerts, D A Phase II Study of Carrisyn © (Acemannan) Alone and with AZT Among Symptomatic and Asymptomatic HIV Patients (P) ABS POS Sixth International Conference on AIDS San Francisco, CA 1990







37 McDaniel, HR HIV-1 Infected Patients Respond Favorably to Oral Acemannan (ACE-M) ABS POS Sixth International Conference on AIDS San Francisco, CA 1990







38 Kemp, MC Concentration-Dependent Inhibition of AIDS Virus Replication and Pathogensis by Acemannan In Vitro ABS POS Sixth International Conference on AIDS San Francisco, CA 1990







39 Chinnah, AD Inhibition of Newcastle Disease Virus Replication and Pathogensis by Acemannan In Vitro ABS The American Society for Virology 1990 Annual Meeting Salt Lake City, UT 1990







40 Thompson, JE Acemannan (ACE-M) Treatment of Acute and Chronic Rhinosinusitis ABS American College of Allergy and Immunology New York, NY 1990







41 Kemp, MC Inhibition of HIV-1 Replication and Pathogenesis by Acemannan In Vitro: Altered Glycosylation and Processing of Env Precursor Glycoproteins ABS VIIIth International Congress of Virology Berlin, West Germany 1990







42 McDaniel, HR An Increase in Circulating Monocyte/Macrophages (M/M) is Induced by Oral Acemannan (Ace-M) in HIV-1 Patients ABS American Society of Clinical Pathologists Fall Meeting Dallas, TX 1990







43 McDaniel, HR The Numbers of Circulating Monocyte/Macrophages (M/M) in Peripheral Blood are of Diagnostic Significant ABS American Society of Clinical Pathologists Fall Meeting Dallas, TX 1990







44 McDaniel, HR Examination of Circulating Macrophage/Monocytes (C-M/M) in Routine Hematology Specimens and Their Significance in Disease POS American Society of Clinical Pathologists Fall Meeting Dallas, TX 1990







45 Carpenter, RH Effect of Acemannan in Treatment of Feline Immunodeficiency Virus Researchers ABS First International Conference of Feline Immunodeficiency Virus Researchers Davis, CA 1991







46 Rosenberg, LJ Improved Feline Peripheral Blood Mononuclear Cell Preparation for Flow Cytometry POS First International Conference of Feline Immunodeficiency Virus Researchers Davis, CA 1991







47 King, G Use of Acemannan as an Aid in the treatment of Fibrosarcoma in Dogs and Cats ABS American College of Veterinary Surgeons (ACVS) 1991 Veterinary Symposium: Small Animal San Francisco, CA 1991







48 King, G Use of Acemannan Immunostimulant as an Aid in the Treatment and Management of Fibrosarcoma in Dogs and Cats ABS Veterinary Cancer Society 11th Annual Conference Minneapolis, MN 1991







49 Tizard, IR Acemannan's Biological Activity and Effect on Norman Murine Sarcoma in Mice ABS Veterinary Cancer Society 11th Annual Conference Minneapolis, MN 1991







50 Yates, KM Use of Acemannan in Treatment of Feline Immunodeficiency Virus Disease ABS Veterinary Cancer Society 11th Annual Conference Minneapolis, MN 1991







51 Carpenter, RH Clinical Applications of a Biological Response Modifier (Acemannan) in Veterinary Clinical Medicine ABS International Congress of Phytotherapy Seoul, Korea 1991







52 Kemp, MC In Vitro Antiviral Effects of a Polydispersed B-(1,4)-Linked Mannan (Acemannan) ABS International Congress of Phytotherapy Seoul, Korea 1991







53 Tizard, IR Immunoregulatory Effects of a Cytokine-Release Enhancer (Acemannan) ABS International Congress of Phytotherapy Seoul, Korea 1991







54 Alvarez, O A Model for the Clinical Evaluation of Partial Thickness Wound Healing in Healthy Human Subjects: The Effects of an Acemannan Hydrogel, an Oak Bark Extract, Occlusive Dressings, and Topical Hyperbaric Oxygen ABS Symposium on Advanced Wound Care New Orleans, LA 1992







55 Eberendu, AR Comparison of Effectiveness of Commercial Wound Cleansers Using an Artificial Wound Environment (AWE) Model Absorption Spectrometry and Gravimetry ABS Symposium on Advanced Wound Care New Orleans, LA 1992







56 Parnell, LS Accelerated Wound Healing Induced bya Complex Carbohydrate POS Wound Healing Society Annual Meeting Richmond, VA 1992







57 Azghani, AO A B-Linked Mannan Inhibits Adherence of P. Aeruginosa to Lung Epithelial Cells ABS ASM General Meeting New Orleans, LA 1992







58 Tizard, IR The Use of Immunostimulante in Animals ABS International Symposium on Veterinary Preventative Medicine Monterrey, Mexico 1992







59 Yates, KM Pilot Study of the Effect of Acemannan in Cats Infected with Feline Immunodeficiency Virus ABS POS Second Annual National Conference on HIV/AIDS Research 1992 Vancouver, British Columbia 1992







60 Parnell, LS The Effect of an Acetylated Mannan on Wound Healing in Guinea Pigs POS European Tissue Repair Society Malmo, Sweden 1992







61 Eberendu, AR A Comparison of the Physiochemical and Effectiveness of Commercial Wound Cleansers ABS Eighth Annual Scientific Session of the Academy of Surgical Research St. Charles, IL 1992







62 Alvarez, O Fundamentals of Chronic Wound Care for Patients in the Home ABS National Association for Home Care Annual Meeting New Orleans, LA 1992







63 Ruedy, J A Randomized Placebo-Controlled Pilot Study of Acemannan Used as an Adjunct to Antiretroviral Therapy: Preliminary Results ABS VIII International Conference on AIDS/III STD World Congress Amsterdam, The Netherlands 1992







64 McDaniel, HREX A Report of Bacteria in Large Activated Circulating Macrophages (CM) on Peripheral Blood Smears Taken at or Near the Time of Blood Culture Collection ABS American Society of Clinical Pathologist Las Vegas, NV 1992







65 McDaniel, HR Clinical Testing and AIDS Treatment Experience with Acemannan: The Antiviral and Anittumor Immunomodulator Isolated From Aloe Barbadensis Miller ABS Zurcher AIDS Kongress Zurich, Switzerland 1992







66 Marshall, GD Human Cytokines Induced by Acemannan ABS American Academy of Allergy and Immunology Chicago, IL 1993







67 Marshall, GD The Role of Immunological Diseases and Wound Healing ABS International Symposium on Wound Healing and Wound Management New Orleans, LA 1992







68 McDaniel, HR The Chernobyl Disaster: Its Highlighting of Environmental Radionucleotide Incorporation in Organs, Acute and Chronic Treatment with an Emphasis on the Care of Children ABS The Dallas-Ft Worth Medical Center Grand Prairie, TX 1992







69 Tizard, IR The Effect of Acemannan on the Healing of Wounds in Experimental Animals ABS International Symposium on Wound Healing and Wound Management New Orleans, LA 1992







70 Tizard, IR Rapid Acceleration of Wound Healing in Young and Old Rats Induced by Application of a Complex Carbohydrate ABS Keystone Symposia-Progress in Basic Research of Wound Repair and its Application to Clinical Managem Silverthorne, CO 1993







71 Marshall, GD In Vitro Stimulation on NK Activity by Acemannan (ACM) ABS Joint Meeting of the American Association of Immunologists and the Clinical Immunology Society Denver, CO 1993







72 Kemp, MC The Antiviral and Immopotentiating Effects of Acemannan: A Polydispersed B-1(1,4)-Linked Acetylated Mannan ABS Cambridge Healthcare Institute Conference on Glycotechnology San Francisco, CA 1993







73 Yates, KM A Comparison of the Effects of Acemannan (ACM) Given by Three Routes of Administration to Feline Immunodeficiency Virus (FIV) Infected Cats ABS Ixth International Conference on AIDS Berlin 1993







74 Singer, J A Randomized Placebo-Controlled Trial of Oral Acemannan as an Adjunctive to Anti-Retroviral Therapy in Advanced HIV Disease ABS POS Ixth International Conference on AIDS Berlin 1993







75 McDaniel, HR CD4 and CD8 Alymphocyte Levels in Acemannan (ACM) Treated Hiv-1 Infected Long-Term Survivors ABS POS Ixth International Conference on AIDS Berlin 1993







76 Karack, K The Effect of Acemannan on Nitric Oxide Production by Chicken Mononuclear Cells and a Macrophage Cell Line ABS 130th Annual Meeting of the AVMA Minneapolis, MN 1993







77 Sharma, JM Reduced Viral Immunodepression in Chickens Treated with an Immunomodulator ABS 130th Annual Meeting of the AVMA Minneapolis, MN 19936







78 Tizard, IR Accelerated Wound Healing Induced by Macrophage Stimulants in Rats: A Genetically Controlled Phenomenon ABS Joint Meeting of the European Tissue Repair Society and Wound Healing Society Amsterdam, Netherlands 1993







79 Lindblad, WJ Enhanced Deposition of Collagen Within Acemannan Impregnated PVA Sponges Implanted into the Rate ABS Joint Meeting of the European Tissue Repair Society and Wound Healing Society Amsterdam, Netherlands 1993







80 Ramamoorthy, L Effect of Acemannan on the Production of Cytokine in a Macrophage Cell Line Raw264.7 ABS Joint Meeting of the European Tissue Repair Society and Wound Healing Society Amsterdam, Netherlands 1993







81 Swaim, SF The Effect of Acemannan on Wound Healing in the Dog ABS Joint Meeting of the European Tissue Repair Society and Wound Healing Society Amsterdam, Netherlands 1993







82 Tizard, IR Comparison of the Effects of Acemannan on Wound Healing in Young, Old, Obese and Old Calorie-Deprived Rats ABS Joint Meeting of the European Tissue Repair Society and Wound Healing Society Amsterdam, Netherlands 1993







83 McAnalley, BH Aloe Vera: An Antiviral? ABS Korean Society of Pharmacognosy International Seminar of Scientific Research on Aloe Seoul, Korea 1993







84 Thompson, JE Upper Respiratory Tract Immunomodulator-Acetyl Mannan ABS PUB 1993 AAOA Annual Meeting Minneapolis, MN 1993







85 Busbee, D Immune Function Differences in Aged and Young Rodents: Effects of an Acetylated B(1,4)-Linked Polymannose as an Immunomodulator ABS American Aging Association 23rd Annual Meeting/American College of Clinical Gerontology 8th Annual M Montreal Quebec, Canada 1993







86 Marshall, GD Cytokine Production in the Elderly: Implications for therapeutic Manipulations ABS American Aging Association 23rd Annual Meeting/American College of Clinical Gerontology 8th Annual M Montreal Quebec, Canada 1993







87 McDade, DM History of Skin Care and the Use of Hydrogels in the Patient Receiving Radiation Therapy PAP ASSRT Mid-Year Meeting Radiation Therapy Session Casa Grande, AZ 1993







88 Rees, T Effect of Acemannan on Oral Aphthous Ulcers in Humans PAP 6 International Symposium on Wound Healing and Wound Management San Francisco, CA 1993







89 Roberts, D The Effects of Acemannan Gel on Experimental Radiation Induced Skin Reactions PAP 6 International Symposium on Wound Healing and Wound Management San Francisco, CA 1993







90 Tizard, IR Use of Immunomodulators to Effect Wound Healing in an Aging Animal Model System ABS American Aging Association 23rd Annual Meeting/American College of Clinical Gerontology 8th Annual M Montreal Quebec, Canada 1993







A01 Danhoff, IE Stabilized Aloe Vera: Effect on Human Skin Cells PUB Drug and Cosmetic Industry 1983;133:52-54, 105-106 1983







A02 McDaniel, HR A Clinical Pilot Study Using Carrisyn in the Treatment of Acquired Immunodeficiency Syndrome (AIDS) PUB AM J Clin Pathol 1987;88:s34 1987







A03 McDaniel, HR Evaluation of Polymannoacetate (Carrisyn) in the Treatment of AIDS PUB Clin Res 1987;35(3):483A 1987







A04 Cuttino, C Pyoderma Gangrenosum: An Innovative Wound Care Protocol PUB J Enterostomal Ther 1987;14:216-219 1987







A05 Ammann, AJ Tumor Necrosis Factors Alpha and Beta in Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex PUB J Clin Immunol 1987;7:481-485 1987







A06 Rodriguez-Bigasm Comparative Evaluation of Aloe Vera in the Management of Burn Wounds in Guinea Pigs PUB Plast Reconstr Surg 1988;81:386-389 1988







A07 Womble, D Enhancement of Allo-Responsiveness of Human Lymphocytes by Acemannan (Carrisyn) PUB Int J Immunopharmacol 1988;10:968-974 1988







A08 Clumeck, N Antiviral Drugs Other Than Zidovudine and Immunomodulating Therapies in Human Immunodeficiency Virus Infection. An Overview PUB AM J MED 1988;85:165-172 1988







A09 Tizard, IR The Biological Activities of Mannans and Related Complex Carbohydrates PUB MOL BIOTHER 1989;1:290-296 1989







A10 Johnson, AR Comparison of Common Topical Agents for Wound Treatment: Cytotoxicity for Human Fibroblasts in Culture PUB WOUNDS 1989;1:186-192 1989







A11 Chien, YW AIDS and Chemotherapy PUB DRUGS TODAY 198;25:19-24 1989







A12 Hodgson, J Capitalizing on Carbohydrates PUB BIOTECHNOLOGY 1990;8:108-111 1990







A13 McMullen, D Wound Healing PUB NURSING CLINICAL CURRENTS 1990;3:1- 4 1990







A14 Cuzzell, JZ Choosing a Wound Dressing: A Systematic Approach PUB AACN CLIN ISSUES CARE NURS 1990;1:566-577 1990







A15 Chinnah, AD Evaluation of the Antiviral, Adjuvant, and Immunomodulatory Effects of a B-(1,4)-Linked Polymannose (Acemannan) DIS TEXAS A&M UNIVERSITY College Station, TX 1990







A16 Pulse, TL A Significant Improvement in a Clinical Pilot Study Utilizing Nutritional Supplements, Essential Fatty Acids and Stabilized Aloe Vera Juice in 29 HIV Seropositive, ARC and AIDS Pts. PUB Advancement in Medicine 1990;3:209-230 1990







A17 Anand, R Sodium Pentosan Polysulfate (PPS), an Anti-HIV Agent Also Exhibits Synergism with AZT, Lymphoproliferative Activity, and Virus Enhancement PUB AIDS Res Hum Retroviruses 1990;6:679-689 1990







A18 Sheets, MA Studies of the Effect of Acemannan on Retorvirus Infections, Clinical Stabilization of Feline Leukemia Virus-Infected Cats PUB MOL BIOTHER 1991;3:41-45 1991







A19 Peng, SY Decreased Mortality of Norman Murine Sarcoma in Mice Treated with the Immunomodulator, Acemannan PUB MOL BIOTHER 1991;3:79-87 1991







A20 Kahlon, JB Inhibition of AIDS Virus Replication by Acemannan in Vitro PUB MOL BIOTHER 1991;3:127-135 1991







A21 Tizard, IR Use of Immunomodulators as an Aid to Clinical Management of Feline Leukemia Virus-Infected Cats PUB J AM VED MED ASSOC 1991;199:1482-1485 1991







A22 Manna, S Evidence of Acetyl Migration During the Methylation of Methyl 2,3,4-Tri-O-Acetyl-D-Mannose with Diazomethane-Boron Trifluoride Etherate PUB Carbohydr Res 1991;222:261-265 1991







A23 Kahlon, JB In Vitro Evaluation of the Synergistic Antiviral Effects of Acemannan in Combination with Azidothymidine and Acyclovir PUB MOL BIOTHER 1991;3:214-223 1991







A24 Harris, C Efficacy of Acemannan in Treatment of Canine and Feline Spontaneous Neoplasms PUB MOL BIOTHER 1991;207-213 1991







A25 Fogleman, RW Subchronic Oral Administration of Acemannan in the Rat and Dog PUB Vet Hum Toxicol 1992;34:144-147 1992







A26 Womble, D The Impact of Acemannan on the Generation and Function of Cytotoxic T-Lymphocytes PUB Immunopharmacol Immunotoxicol 1992;14:63-77 1992







A27 Swaim, SF Effects of Topical Medications on the Healing of Open Pad Wounds in Dogs PUB Journal of the American Animal Hospital Association 1992;28:499-502 1992







A28 Yates, KM Pilot Study of the Effect of Acemannan in Cats Infected with Feline Immunodeficiency Virus PUB VET Immunol Immunopathol 1992;35:177-189 1992







A29 Fogleman, RW Toxicologic Evaluation of Injectable Acemannan in the Mouse, Rat, and Dog PUB Vet Hum Toxicol 1992;34:201-205 1992







A30 Parnell, LS Effect of Acemannan on Wound Healing MAS THE TEXAS A&M UNIVERSITY College Station, TX 1992







A31 Tizard, IR Carbohydrates, Immune-Stimulating BOOK Encyclopedia of Immunology San Diego, CA 1992







A32 Chinnah, AD Antigen Dependent Adjuvant Activity of a Polydispersed B-(1,4)-Linked Acetylated Mannan (Acemannan) PUB Vaccine 1992;10:551-557 1992







A33 Womble, D The Impact of Acemannan on the Generation and Function of Cytotoxic T-Lymphocytes PUB Immunopharmacol Immunotoxicol 1992;14:63-77 1992







A34 Tizard, IR Veterinary Immunology an Introduction BOOK W B Sauders Co. Harcourt Brace Jovanovich, INC. Philadelphia, PA 1992







A35 Smalley, RV Chemical Inducers of Lymphokines BOOK Principles of Cancer Biotherapy, RK Oldham, Marcel Dekker, INC New York, NY 1992







A36 Marshall, GD Cytokines: Clinical Potentials for the Allergic Pt PUB Allergy Proc 1992;13:311-315 1992







A37 McDaniel, HREX A Report of Bacteria in Large Activated Circulating Macrophages (CM) on Peripheral Blood Smears Taken at or Near the Time of Blood Culture Collection ABS PUB AM J CLIN PATHOL 1992;98:373 1992







A38 Ererendu, AR A Comparison of the Physicochemical and Effectiveness of Commercial Wound Cleansers ABS PUB J Invest Surg 1992;5:3 1992







A39 Garnett, PB Immunostimulants Brings Positive Results in Studies PUB Veterinary Forum 1933;(March):74 1993







A40 Marshall, GD Human Cytokines Induced by Acemannan ABS PUB J Allergy Clin Immunol 1993;91:295 1993







A41 Marshall, GD In Vitro Stimulation of NK Activity by Acemannan (ACM) ABS PUB J Immunol 1993;150(8):1381 1993







A42 Mac Ewen, EG Recent Advances in the Biologic Therapy of Cancer PUB Small Animal Oncology 1993:15(7):909-922 1993







A43 Mata, JS Skin and Wound Care Management PUB Clinical Case Updates 1993;4(4) 1993







A44 Tizard, IR Accelerated Wound Healing Induced by Macrophage Stimulants in Rats: A Genetically Controlled Phenomenon ABS PUB Wound Repair and Regeneration 1993;1(2):130 1993







A45 Manna, S Determination of the Position of the O-Acetly Group in a B-(1,4)-Mannan (Acemannan) From Aloe Barbardensis Miller PUB Carbohydrates 1993;241:317-319 1993







A46 Wright, RW Fibroblast Cytotoxicity and Blood Cell Integrity Following Exposure to Dermal Wound Cleansers PUB Ostomy Wound Manage 1993;39:33-40 1993

undefined undefined undefined undefined undefined undefined